RA208 Post Approval Submissions and Compliance: Prescription Drugs and Biologics

Post-approval submissions and compliance is an ongoing regulatory requirement that pharmaceutical companies must follow after a prescription drug or biologic is approved for marketing and sale. These requirements are designed to ensure that the product continues to be safe and effective for patients and that the manufacturing processes remain in compliance with regulatory standards.

Compliance with these post-approval requirements is critical for pharmaceutical companies to maintain their product’s regulatory approval and ensure continued access to the market. Failure to comply with regulatory requirements may result in enforcement actions, such as fines or product recalls, that could have significant financial and reputational consequences for the company.

The post-approval submissions and compliance requirements for prescription drugs and biologics generally include topics such as adverse event reporting, labeling updates, manufacturing changes and annual reports.

Learning Points:

• Post-Market Requirements and Commitments
• Changes to an Approved Application for drugs and biologics
• Risk Evaluation and Mitigation Strategies
• Post-marketing Reporting of Adverse Experiences
• Product Complaints and Recalls
• Annual Reports
• Advertising and Labelling
• Changes to Drug Master Files Affecting Approved Applications
• Approved Application Inactivation or Withdrawal
• Change in Sponsor (Transfer of Ownership) of an Approved Application